Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, parallel-group, multi-center study to
determine the effect of ranolazine when added to glimepiride on glycemic control in adults
with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current
treatment with stable sulfonylurea or metformin therapy in addition to diet and exercise.